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There have been incredible strides in imaging technology over the past 40 years. Where 
scientists were once blind to the structure, 
chemistry and function of the living brain, they 
are now able to extract detailed information using 
structural, chemical and functional magnetic 
resonance imaging. 
From these methods, new understanding of the 
precursors and the bases of psychiatric disorders in 
the brain have emerged that one day may lead to 
more effective therapies for numerous disorders. 
Using these methods effectively is a challenge 
facing a team of psychiatrists from Wayne State’s 
divisions of Child and Adolescent Psychiatry and 
Brain Research and Imaging Neuroscience. Drs. 
David Rosenberg, Jeffrey Stanley and Vaibhav 
Diwadkar have joined forces to try to understand 
the vulnerability for, and the bases of, psychiatric 
diseases such as attention deficit hyperactivity 
disorder, obsessive compulsive disorder and more in 
children and adolescents.
Brain tracking
According to the National Institutes of Mental 
Health (NIMH), attention deficit hyperactivity 
disorder (ADHD) is one of the most common 
childhood illnesses, affecting 3 percent to 9 
percent of children, and accounting for 30 percent 
to 40 percent of child referrals to mental health 
services. In addition, the condition can persist into 
adulthood in nearly 60 percent of cases, affecting 4 
percent of adults.
One study at WSU using brain imaging 
technologies and other forms of testing will track 
the development of ADHD in the brains of children 
and teens.  
 “The primary aim is to track at what age and 
where in the brain developmental differences start 
to occur in ADHD compared to the developmental 
course of healthy individuals,” said Jeffrey Stanley, 
Ph.D., associate professor of psychiatry and 
behavioral neurosciences, co-director of the Division 
of Brain Research and Imaging Neuroscience, 
and program director and graduate officer of the 
Translational Neuroscience Program in the School 
of Medicine. 
“The cause and progression of this illness is 
poorly understood biochemically, anatomically 
and functionally,” Stanley said. “The goal of this 
study, funded by the NIMH, is to map out the 
developmental course of ADHD using neuroimaging 
biomarkers and to identify at what age and where 
in the brain changes are occurring in ADHD that 
deviate from the normal development course of 
healthy children. Certain brain areas or networks 
mature earlier than others, and we anticipate 
seeing neuroimaging alterations occurring in later 
maturing areas, such as the prefrontal cortex, that 
were potentially influenced by maldeveloped earlier 
brain areas.”
“By conducting functional imaging studies  
in parallel to studies of structure and chemistry, 
we will also be able to assess the impact of 
altered neurodevelopment on the functions of 
developing networks in the brain - networks that 
are important for basic and lifelong behaviors such 
as attention, memory and emotion,” said Vaibhav 
Diwadkar, Ph.D., assistant professor of psychiatry 
and behavioral neurosciences and co-director 
of the Division of Brain Research and Imaging 
Neuroscience.
The age that brain networks change in children 
with ADHD or how those early impaired networks 
influence other networks within the brain is 
unknown. Early identification of affected networks 
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“Initial findings at Wayne State 
University have shown that  
glutamate plays a key role in 
OCD, Glutamate is the brain’s light 
switch that helps turn serotonin 
and other chemicals off  and on. 
Our research has shown that glu-
tamate abnormalities in OCD have 
significant treatment implications. 
This new study will further our 
research by combining imaging 
and genetics, something never 
assessed in OCD patients.”
— Dr. David Rosenberg
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and charting changes, Stanley said, is critical for 
researchers to gain a greater understanding of the 
development and progression of the condition, and 
in developing more-effective therapies.
“The early identification of impaired networks 
and charting temporally impaired networks in 
ADHD is critical in gaining a greater understanding 
of the development and progression of ADHD,” 
Stanley said. “This will result in developing 
better targeted and age-appropriate cognitive and 
behavioral therapy for ADHD.”
Combining imaging and genetics
Wayne State is leading the first-ever combined 
imaging and genetics research study on obsessive-
compulsive disorder (OCD) in child psychiatry, 
funded by the National Institute of Mental Health 
at the National Institutes of Health.
The project, Brain Chemistry and Genetics in 
Pediatric OCD, led by WSU, with collaborative 
partners at the University of Michigan and the 
University of Toronto/The Hospital for Sick 
Children (SickKids), is focused on OCD, a severe, 
prevalent and chronically disabling disease. OCD 
affects approximately 1 percent to 3 percent of the 
population nationwide and about 50 percent of all 
OCD cases begin in childhood and adolescence.
“Initial findings at Wayne State University 
have shown that glutamate plays a key role in 
OCD,” said David Rosenberg, M.D., the Miriam L. 
Hamburger Endowed Chair of Child Psychiatry and 
professor of psychiatry in the School of Medicine 
at Wayne State University and the principal 
investigator of the project. “Glutamate is the brain’s 
light switch that helps turn serotonin and other 
chemicals off and on. Our research has shown that 
glutamate abnormalities in OCD have significant 
treatment implications. This new study will further 
our research by combining imaging and genetics, 
something never assessed in OCD patients.”
By performing critical imaging and genetic 
tests of glutamate genes in 200 OCD and 200 
healthy control patients, this group of scientists 
aims to examine glutamate changes in brain 
regions implicated in OCD, and to combine this 
information with a detailed exploration of variants 
within genes influencing glutamate transmission.
Brain processes visualized using magnetic 
resonance imaging are thought to be closer to the 
action of genes compared with complex behavioral 
phenomena like OCD. By combining the two 
powerful techniques of neuroimaging and genetics, 
Rosenberg and his collaborators hope to speed the 
discovery of risk genes.
Results will have significant scientific  
implications as well as key “translational” 
importance in bringing research from the bench 
to the bedside with clinical ramifications. By 
combining unique clinical assessment, magnetic 
resonance imaging and genetics expertise, the team 
of researchers will investigate biological, genetic 
and behavioral variables that may one day lead to a 
better understanding of pediatric OCD, and in turn,  
the development of new diagnostic and  
treatment approaches.
For more information visit: http://brain.wayne.edu
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About Dr. Vaibhav Diwadkar:         
Dr. Diwadkar received a B.S. in psychology and 
Computer Science from Coe College, Iowa. He 
received a Ph.D. in cognitive science and psychology 
from Vanderbilt University. He joined Wayne State 
University in 2005. 
About Dr. David Rosenberg:          
Dr. Rosenberg received a B.S. in biomedical science 
and a M.D. in general psychiatry from the University 
of Michigan. He completed his general and child 
psychiatry residency at the University of Pittsburgh 
and post-doctoral research fellowship at the National 
Institute of Mental Health. He joined Wayne State 
University in 1996. 
About Dr. Jeffrey Stanley:           
Dr. Stanley received a B.S. and M.S. in physics from 
the University of Waterloo, and a Ph.D. in medical 
biophysics from the University of Western Ontario. He 
joined Wayne State University in 2004.
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